EPO and cancer: In this regard, we have examined several cancer cell lines (DLD1, HepG2, P39, T98G, PC-3, G361, SCH), of which expression levels of Epo and EpoR are already known, to investigate whether rhEpo triggered and EMP9 inhibited tyrosine phosphorylation of STAT5 [37].